The Korea Advanced Institute of Science and Technology (KAIST) researchers have developed a way to reprogram immune cells already inside tumours into cancer-killing machines.
Seoul [South Korea], October 21 (ANI/Global Economic): An anticancer treatment 'CAR-T (chimeric antigen receptor T-cell),' called a miracle anticancer drug, has been developed and the first clinical trial in Korea is being conducted.
Seoul [South Korea], July 8 (ANI): A joint research group from KAIST (Korea Advanced Institute of Science and Technology) and Institut Pasteur Korea has identified repurposed drugs for COVID-19 treatment through virtual screening and cell-based assays.